StockNews.com assumed coverage on shares of ARCA biopharma (NASDAQ:ABIO – Free Report) in a research note issued to investors on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. ARCA biopharma Price Performance Shares of NASDAQ ABIO opened at $2.06 on Friday. The business’s 50 day moving average price is $2.04 and […]